Novel inhalational murine model of invasive pulmonmy aspergillosis

被引：112
作者：
Sheppard, DC
Rieg, G
Chiang, LY
Filler, SG
Edwards, JE
Ibrahim, AS
机构：
[1] Harbor UCLA Res & Educ Inst, Div Infect Dis, St Johns Cardiovasc Res Ctr, Dept Med, Torrance, CA 90502 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 05期
关键词：
D O I：
10.1128/AAC.48.5.1908-1911.2004
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We developed a novel model of invasive aspergillosis (IA) that recapitulates human disease. Mice were immunosuppressed with cyclophosphamide and cortisone acetate and then infected in an aerosol chamber. This procedure reproducibly delivered 1x10(3) to 3x10(3) conidia to the lungs. Lethal pulmonary IA developed over 2 weeks and was prevented by amphotericin B.
引用
收藏
页码：1908 / 1911
页数：4
相关论文
共 11 条
  • [1] Therapeutic outcome in invasive aspergillosis
    Denning, DW
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) : 608 - 615
  • [2] An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome
    Denning, DW
    Marinus, A
    Cohen, J
    Spence, D
    Herbrecht, R
    Pagano, L
    Kibbler, C
    Kcrmery, V
    Offner, F
    Cordonnier, C
    Jehn, U
    Ellis, M
    Collette, L
    Sylvester, R
    [J]. JOURNAL OF INFECTION, 1998, 37 (02) : 173 - 180
  • [3] SCH56592 treatment of murine invasive aspergillosis
    Graybill, JR
    Bocanegra, R
    Najvar, LK
    Luther, MF
    Loebenberg, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (04) : 539 - 542
  • [4] Trends in the postmortem epidemiology of invasive fungal infections at a university hospital
    Groll, AH
    Shah, PM
    Mentzel, C
    Schneider, M
    JustNuebling, G
    Huebner, K
    [J]. JOURNAL OF INFECTION, 1996, 33 (01) : 23 - 32
  • [5] Efficacy of TAK-457, a novel intravenous triazole, against invasive pulmonary aspergillosis in neutropenic mice
    Hayashi, R
    Kitamoto, N
    Iizawa, Y
    Ichikawa, T
    Itoh, K
    Kitazaki, T
    Okonogi, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) : 283 - 287
  • [6] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
    Herbrecht, R
    Denning, DW
    Patterson, TF
    Bennett, JE
    Greene, RE
    Oestmann, JW
    Kern, WV
    Marr, KA
    Ribaud, P
    Lortholary, O
    Sylvester, R
    Rubin, RH
    Wingard, JR
    Stark, P
    Durand, C
    Caillot, D
    Thiel, E
    Chandrasekar, PH
    Hodges, MR
    Schlamm, HT
    Troke, PF
    de Pauw, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) : 408 - 415
  • [7] Aspergillus fumigatus and aspergillosis
    Latgé, JP
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (02) : 310 - +
  • [8] Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients
    Marr, KA
    Carter, RA
    Crippa, F
    Wald, A
    Corey, L
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (07) : 909 - 917
  • [9] METCHNIKOFF E, 1968, IMMUNITY INFECT DIS, V61
  • [10] IMMUNIZATION WITH EXTRACELLULAR PROTEINS OF MYCOBACTERIUM-TUBERCULOSIS INDUCES CELL-MEDIATED IMMUNE-RESPONSES AND SUBSTANTIAL PROTECTIVE IMMUNITY IN A GUINEA-PIG MODEL OF PULMONARY TUBERCULOSIS
    PAL, PG
    HORWITZ, MA
    [J]. INFECTION AND IMMUNITY, 1992, 60 (11) : 4781 - 4792
12